Athira Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Athira Pharma's estimated annual revenue is currently $7.6M per year.
- Athira Pharma's estimated revenue per employee is $110,072
- Athira Pharma's current valuation is $412.7M. (January 2022)
Employee Data
- Athira Pharma has 69 Employees.
- Athira Pharma grew their employee count by 38% last year.
Athira Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO & CBO | Reveal Email/Phone |
2 | VP, Head Biometrics & Data Management | Reveal Email/Phone |
3 | VP Regulatory Affairs | Reveal Email/Phone |
4 | VP, Program and Portfolio Management | Reveal Email/Phone |
5 | SVP CMC and Technical Operations | Reveal Email/Phone |
6 | General Counsel | Reveal Email/Phone |
7 | VP Clinical Operations | Reveal Email/Phone |
8 | VP, Head Global Patient Safety & Pharmacovigilance | Reveal Email/Phone |
9 | Controller | Reveal Email/Phone |
10 | EVP, People | Reveal Email/Phone |
Athira Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Athira Pharma?
Athira Pharma is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. Our innovative approach is focused on turning brain degeneration into regeneration, achieved by re-establishing lost connections and restoring lost function.
keywords:N/A
N/A
Total Funding
69
Number of Employees
$7.6M
Revenue (est)
38%
Employee Growth %
$412.7M
Valuation
N/A
Accelerator
Athira Pharma News
Richard Kayne. (Kayne Anderson Capital Advisors Photo). A billionaire investor of Athira Pharma is calling for the ouster of the Seattle...
BOSTON, March 30 (Reuters) - Billionaire investor Richard (Ric) Kayne is seeking two board seats at Athira Pharma (ATHA.
About Athira Pharma, Inc. Athira Pharma Inc., headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.2M | 69 | 6% | N/A |
#2 | $9M | 69 | N/A | N/A |
#3 | $13.9M | 69 | 10% | N/A |
#4 | N/A | 69 | 44% | N/A |
#5 | $11.2M | 69 | 8% | N/A |